Donate
Email Password
Not a member? Sign Up   Forgot password?
Business and Economics Education Environment Health Care California
Home
About PRI
My PRI
Contact
Search
Policy Research Areas
Events
Publications
Press Room
PRI Blog
Jobs Internships
Scholars
Staff
Book Store
Policy Cast
Upcoming Events
WSJ's Stephen Moore Book Signing Luncheon-Rescheduled for December 17
12.17.2012 12:00:00 PM
Who's the Fairest of Them All?: The Truth About Opportunity, ... 
More

Recent Events
Victor Davis Hanson Orange County Luncheon December 5, 2012
12.5.2012 12:00:00 PM

Post Election: A Roadmap for America's Future

 More

Post Election Analysis with George F. Will & Special Award Presentation to Sal Khan of the Khan Academy
11.9.2012 6:00:00 PM

Pacific Research Institute Annual Gala Dinner

 More

Reading Law: The Interpretation of Legal Texts
10.19.2012 5:00:00 PM
Author Book Signing and Reception with U.S. Supreme Court Justice ... More

Opinion Journal Federation
Town Hall silver partner
Lawsuit abuse victims project
Press Archive
E-mail Print Avastin: Helpful drug or too risky, expensive?
Fwdailynews.com
By: Sally C. Pipes
10.3.2010

In an “Urgent Submission on Breast Cancer” to newspaper editors, Sally C. Pipes (president and CEO of the Pacific Research Institute and author of “The Truth About Obamacare”) outlined only the positive parts of the Avastin story and implied that saving money was the real reason for this recommendation. She states, “One can only hope that the Obama Administration defends a woman’s right to choose Avastin.”

Read more at http://www.fwdailynews.com/index.php?option=com_content&view=article&id=9044:Avastin:-Helpful-drug-or-too-risky,-expensive?&catid=100:terry-gaff.

Submit to: 
Submit to: Digg Submit to: Del.icio.us Submit to: Facebook Submit to: StumbleUpon Submit to: Newsvine Submit to: Reddit
Within Press
Browse by
Recent Publications
Press Archive
Powered by eResources